WHO ICTRP trial
To evaluate if the application of platelet rich plasma on the skin in the…
CTRI/2024/04/065327 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/04/065327 |
|---|---|
| Public title | To evaluate if the application of platelet rich plasma on the skin in the radiation site, during radiation treatment will reduce radiation induced skin reactions in patients of head and neck and breast cancer receiving radiotherapy. |
| Scientific title | Comparison of best supportive care with or without topical autologous platelet rich plasma as a prophylactic agent for reducing acute radiation dermatitis: a randomized controlled study. - NIL |
| Primary sponsor | Dr. Ebenezer Staines |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: C50-C50- Malignant neoplasms of breast Health Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx |
| Interventions | Intervention1: Topical application of platelet rich plasma on the radiation treatment site.: The platelet rich plasma (PRP) for topical application will be derived from the patient themselves. Prior to the start of radiation treatment… |
| Registration date | May 4, 2024 |
| Target size | 120 |
| Secondary IDs | JIP/IEC/2024/01/11 Version: 1.1 Date: 05/03/24 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: